Since 2016, Duncan|Stubbs has represented over 20,000 people who believe their cancer diagnosis stems from using Roundup weed killer for years. Its active ingredient, glyphosate, was classified as a probable human carcinogen by the World Health Organization (WHO) in 2015. And yet, Bayer continued to market and sell it until 2023.
Every client’s story is different, but one thread connects the vast majority of cases: They trusted the manufacturer when they said it was safe to use.
As our firm continues to accept new Roundup cases and stand up to Bayer on behalf of innocent people, we want to spread awareness of this negligence so victims are empowered to get the justice they deserve and to prevent this from happening to future generations.
With that in mind, we have provided a comprehensive overview of Roundup, its uses, risks, links to cancer, and the ensuing waves of lawsuits as victims fight back against corporate negligence.
If you believe Roundup harmed you or a loved one, contact Duncan|Stubbs today for a risk-free, no-cost case review. Bayer has set aside billions to settle with victims. We are still accepting cases with the goal of securing maximum compensation for our clients. If we do not win your case, you pay $0 in legal fees.
The original formula for Roundup weed killer contained glyphosate as an active ingredient. In 2015, the WHO’s International Agency for Research on Cancer (IARC) identified glyphosate as “probably carcinogenic in humans.” It specifically linked prolonged exposure to glyphosate to an increased risk for non-Hodgkin’s lymphoma (NHL).
The FDA and EPA conducted their own studies to confirm the WHO’s findings. They maintain that glyphosate is safe for use.
Monsanto invented Roundup weed killer in the 1970s. Initially developed for agricultural use, It quickly gained popularity due to its effectiveness in killing a wide range of weeds and grasses.
Over the years, Roundup has become widely used not only in agriculture but also in residential landscaping, commercial weed control, and even by government agencies for maintaining public spaces. Its convenience, affordability, and effectiveness have made it a go-to solution for weed control around the world.
However, Roundup’s widespread use has been controversial due to its link to non-Hodgkin’s lymphoma, a type of cancer that affects the lymphatic system.
Since the WHO’s revelation in 2015, victims have begun coming forward to share their stories and demand compensation from Bayer, alleging that exposure to Roundup contributed to the development of their disease.
Multiple epidemiological studies have investigated the association between glyphosate exposure and non-Hodgkin’s lymphoma risk.
A published in the International Journal of Environmental Research and Public Health in 2019 analyzed data from over 54,000 licensed pesticide applicators in the United States. The study found an association between glyphosate exposure and an increased risk of NHL, particularly among individuals with the highest cumulative exposure levels.
Additionally, a meta-analysis published in the Journal of Environmental Science and Health in 2019 reviewed 15 studies on glyphosate exposure and NHL risk. The meta-analysis concluded that there was a positive association between glyphosate exposure and NHL risk, supporting the hypothesis that glyphosate may act as a potential carcinogen.
Other studies include:
Other than non-Hodgkin’s lymphoma, glyphosate has been linked to diseases like:
The vast majority of Roundup cancer cases stem from residential use, but the risk extends far outside the home. Those who may be at risk include:
In 2021, Bayer announced that glyphosate would be removed from residential weed killer beginning in 2023. However, the glyphosate formula is still being sold to and used by commercial agriculture operations, including farmers.
The original residential Roundup formula was an effective weed killer, but there are alternatives even beyond the new formula from Bayer. They include:
Always be sure to follow the manufacturer’s instructions when handling these substances.
Since 2016, Duncan|Stubbs has represented over 20,000 clients who allege their cancer diagnosis was caused by prolonged exposure to Roundup. Each and every case is handled and fought with the utmost care, led by some of the most respected and experienced lawyers in the field.
We understand that every story is different, and so a personalized legal strategy is key. There is no one-size-fits-all mentality at Duncan|Stubbs.
Finally, we have a proud reputation of refusing to back down until our clients receive maximum recoveries. Litigation will continue until we go to trial, or Bayer pays clients what they’re owed–no less.
Step 1: Contact Duncan|Stubbs
We’ll ask a few questions and determine if you may have a qualifying case.
Step 2: Gather information
With your permission, we’ll gather all the information and evidence needed to build and win your case.
Step 3: Get justice
We’ll fight to secure maximum compensation for you and your family. There are no fees unless you’re awarded a settlement.
Duncan|Stubbs Roundup lawsuits are pending around the country, and we are currently accepting new cases to ensure as many victims as possible receive compensation.
As always, Duncan|Stubbs charges nothing for its services unless a settlement is awarded.
If you or someone you love used Roundup weed killer and were later diagnosed with non-Hodgkin’s lymphoma (NHL), you may be owed compensation. Symptoms include:
The Roundup controversy began in 2015 when the World Health Organization’s cancer research arm classified glyphosate, the weed killer’s active ingredient, as a probable human carcinogen. That means it’s likely to cause cancer – in this case, non-Hodgkin’s lymphoma.
These findings conflicted with a report from the U.S. Environmental Protection Agency, which would be published just a year later. As part of their registration review, the EPA conducted studies that determined glyphosate was not a carcinogen.
With such a discrepancy between the reports, a panel of researchers was gathered to review the EPA’s findings. Their review raised questions about how data was evaluated and whether or not proper protocols were followed while testing glyphosate. The EPA maintained its findings in 2019.
Empowered by the WHO’s report and others contradicting the EPA’s findings, victims began telling their stories. Lawsuits rolled in by the hundreds, with plaintiffs alleging their cancer was caused by using Roundup weed killer at home or on the job and that Bayer did not adequately warn consumers of the possible risks associated with using the product.
The scientific evidence on its own was damning enough. However, Bayer suffered another embarrassment when memos were shared in court, which put the company’s negligence on full display throughout a case involving a school groundskeeper named Dewayne Johnson.
During the trial, it was revealed that Monsanto, the original manufacturer of Roundup, was aware of the increased risk of cancer and worked to cover up the evidence. There was also a plot to discredit the WHO’s original report that classified glyphosate as a probable carcinogen.
Records include discussions about ghostwriting scientific papers on glyphosate, with authors supporting the claim that weed-killer products were safe to use. There were also plans to attack the World Health Organization’s credibility and call into question its findings that classified glyphosate as a probable carcinogen.
Most people who file a Roundup lawsuit have been diagnosed with non-Hodgkin’s lymphoma themselves or have a loved one who was diagnosed. In general, you or your loved one may qualify for a lawsuit if:
If you’re facing the loss of a loved one due to Roundup exposure, please know you still have the legal right to pursue justice on their behalf.
The worth of a Roundup settlement can vary significantly based on factors such as the number of plaintiffs involved, the severity of their health conditions, the strength of evidence linking Roundup to their illnesses, and the decisions of the court or parties involved in the settlement negotiations.
Some individual settlements have ranged from thousands to millions of dollars. Additionally, large class-action settlements have involved hundreds of millions or even billions of dollars. It’s important to note that each case is unique, and the settlement amount depends on various factors specific to that case.
Every person’s story is unique, so the outcome of every case will be different depending on the specific circumstances involved, including:
Ultimately, a jury or negotiations between parties will determine the final Roundup settlement amount.
January 2024:
A Philadelphia Common Pleas Court ordered Bayer to pay a staggering $2.25 billion to a man who was diagnosed with non-Hodgkin’s lymphoma after using Roundup weed killer in his yard for two decades. “The jury’s unanimous verdict was a condemnation of 50 years of misconduct by Monsanto and a declaration that its misconduct was in reckless disregard of human safety and a substantial cause of his cancer,” his attorneys said in a statement.
While these types of significant verdicts are outliers, they continue to increase pressure on Bayer/Monsanto to resolve their outstanding cases as quickly as possible.
November 2023:
A Missouri jury ordered Bayer to pay $1.56 billion to three Duncan Stubbs clients who claimed the company’s Roundup weedkiller caused their non-Hodgkin’s lymphoma. The jury found that Bayer’s Monsanto business was liable for claims of negligence, design defects and failing to warn plaintiffs of the potential dangers of using Roundup. Each plaintiff was diagnosed with non-Hodgkin’s lymphoma that they alleged was caused by using Roundup on their family property. This monumental verdict is also great news for you, as it strengthens our firm’s position to negotiate for the best possible compensation for all Duncan Stubbs clients.
October 2023:
Over the span of just 2 weeks, Bayer was dealt half a billion in verdict losses as courts sided with the people in 3 trials. A California jury awarded $332 million in damages after they found a man’s use of Roundup on his lawn for three decades led to his non-Hodgkin’s lymphoma diagnosis. A retired restaurant owner was awarded $175 million in Philadelphia after developing NHL after 20 years of Roundup use. And a St. Louis jury awarded a man who had been in remission from NHL for a decade $1.25 million after ruling Bayer failed to properly warm consumers of the potential risks of its weed killer.
If you believe you or your loved one’s cancer is linked to Roundup exposure, Duncan|Stubbs is here to provide a free, no-obligation case review to determine your potential eligibility for a settlement. There are no legal fees unless you win. Contact us today to learn how we can champion your fight against corporate negligence.
Free Case Review
No fee unless you receive compensation.
"*" indicates required fields